JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. Academic Article uri icon

Overview

publication date

  • September 17, 2018

Identity

PubMed Central ID

  • PMC6159958

Scopus Document Identifier

  • 85054445731

Digital Object Identifier (DOI)

  • 10.1172/JCI124920

PubMed ID

  • 30222137

Additional Document Info

volume

  • 128

issue

  • 10